Operating
Accretion (Amortization) of Investment Discounts and Premiums
Roivant Sciences Accretion (Amortization) of Investment Discounts and Premiums decreased by 11.2% to $8.72M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 70.2%, from $29.27M to $8.72M.
Analysis
StatementCash Flow Statement
SectionOperating
First reportedQ1 2022
Last reportedQ3 2025Feb 6, 2026
Metric ID:
isrg_accretion_amortization_investment_discountsHistorical Data
13 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $25.04M | $29.27M | $15.66M | $11.06M | $9.82M | $8.72M |
| QoQ Change | — | — | — | — | — | — | — | — | +16.9% | -46.5% | -29.3% | -11.2% | -11.2% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | -60.8% | -70.2% |
Range$0.00 – $29.27M
Avg YoY Growth-65.5%
Median YoY Growth-65.5%
Current Streak4 quarters decline
Accretion (Amortization) of Investment Discounts and Premiums at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's accretion (amortization) of investment discounts and premiums?
- Roivant Sciences (ROIV) reported accretion (amortization) of investment discounts and premiums of $8.72M in Q4 2025.
- How has Roivant Sciences's accretion (amortization) of investment discounts and premiums changed year-over-year?
- Roivant Sciences's accretion (amortization) of investment discounts and premiums decreased by 70.2% year-over-year, from $29.27M to $8.72M.